Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10307416
Oligomer-opioid agonist conjugates
granted -
US 10307398
Resuscitation composition and methods of making and using
granted -
US 10306874
Non-human animals having a humanized lymphocyte-activation gene 3
granted -
US 10307386
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted -
HR P20190642
ARIPIPRAZOLE PRODRUG COMPOSITIONS
granted -
IL 265680
Dimeric contrast agents
granted -
US 2019161472
NEW ANTIBACTERIAL COMPOUNDS
granted -
US 10300134
Vaccine formulations and methods of preparation and use thereof
granted -
US 10301292
Bicyclic compound
granted -
US 10301622
Quantification and spatio-temporal tracking of a target using a spherical nucleic acid (SNA)
granted -
US 10301371
Cyclic monomer and dimer peptides having integrin antagonist activity
granted -
US 10301323
Histone deacetylase inhibitors
granted -
US 10301304
Selective inhibitor of phosphatidylinositol 3-kinase-gamma
granted -
US 10300150
Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
granted -
US 10300113
Targeted therapeutic proteins
granted -
US 10300074
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
granted -
US 10300073
Use of CDK9 and BRD4 inhibitors to inhibit inflammation
granted -
US 10300027
Effective sensitizing dose of a gelled immunomodulating topical composition
granted -
US 10300047
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease
granted -
US 10300010
Methods for delivering entanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10300036
Compositions and methods for treating and preventing lung injury
granted -
US 10301369
Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
granted -
US 10301365
Met e 1 tropomyosin variants for use in allergen-specific immunotherapy
granted -
US 10301317
Inhibitors of ERK and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.